Evidence-based Pharmacogenomics: the Case of Warfarin

Genomics|Update|Current

Evidence-based Pharmacogenomics: the Case of Warfarin

Does pharmacogenetics have a role in the dosing of vitamin K antagonists?
Bruce Furie, New England Journal of Medicine, Nov 19

 A pharmacogenetic versus a clinical algorithm for warfarin dosing
Kimmel S, et al. New England Journal of Medicine 2013 Nov 19
A randomized trial of genotype-guided dosing of warfarin.
Pirmohamed M, et al. New England Journal of Medicine 2013 Nov 19
Genetic data does not improve anticoagulation control with warfarin, NIH News, Nov 19
EGAPP evidence-based approach to the evaluation of pharmacogenomics and other genomic applications in practice
CDC blog post Medications for the masses? Pharmacogenomics is an important public health issue (2011)